IDO1 and neoplasm: Which indicates that the vaccine-induced T cells can simultaneously recognize IDO/PD-L1-expressing tumor cells, reprogram the immunosuppressive tumor microenvironment towards an inflammatory state and enhance anti-tumor efficacy.